| Enrolling By Invitation | RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial Severe Aplastic Anemia | — | 2021-10-01 |
| Completed | ECP Combination Study Steroid Refractory GVHD | — | 2021-04-13 |
| Completed | Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation Central Nervous System Infections, Central Nervous System Complication, Infectious Disease of Nervous System | — | 2021-01-01 |
| Unknown | Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplanta Multiple Sclerosis | — | 2021-01-01 |
| Unknown | EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2) Autoimmune Diseases | — | 2019-07-01 |
| Completed | A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic H Pneumocystis Pneumonia | — | 2016-03-01 |
| Unknown | Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation Invasive Aspergillosis | — | 2016-01-01 |
| Completed | Current Treatment of HCV Infection After HSCT Hepatitis C | — | 2015-12-01 |
| Completed | hATG+CsA vs hATG+CsA+Eltrombopag for SAA Severe Aplastic Anemia | Phase 3 | 2015-07-01 |
| Completed | Gram-negative Bacteremia in HSCT Recipients Allogeneic or Autologous HSCT | — | 2014-02-01 |
| Completed | EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients Autoimmune Diseases | — | 2012-12-01 |
| Completed | Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL) CLL | — | 2010-08-01 |
| Terminated | Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia Chronic Myeloid Leukemia | Phase 2 | 2010-02-01 |
| Completed | Effect of 2nd Gen TKI in CML Myeloid Leukemia, Chronic | — | 2010-01-01 |
| Terminated | HCT Versus CT in Elderly AML Acute Myeloid Leukemia | Phase 3 | 2010-01-01 |
| Completed | Allo SCT in Amyloidosis Non-interventional Study AL Amyloidosis | — | 2009-12-01 |
| Completed | Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML MDS, CMML | — | 2009-11-01 |
| Withdrawn | Autologous Stem Cell Transplantation: International Lupus Trial REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS | Phase 2 / Phase 3 | 2009-07-01 |
| Completed | Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia Aplastic Anemia | Phase 2 | 2008-08-01 |
| Withdrawn | Palifermin After Haploidentical PBSCT Non-Hodgkin's Lymphoma or Hodgkin's Disease, Acute Leukaemia, Myelodysplastic Syndrome | Phase 2 | 2008-02-01 |
| Terminated | Myfortic - Treatment for Extensive cGvHD Graft vs Host Disease | Phase 3 | 2006-09-01 |
| Terminated | ASTIC Autologous Stem Cell Transplantation for Crohn's Disease Crohn Disease | Phase 3 | 2006-06-01 |
| Completed | Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of D Hepatic Veno-Occlusive Disease | Phase 2 / Phase 3 | 2005-12-01 |
| Terminated | MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation Multiple Myeloma | Phase 3 | 2005-07-01 |
| Terminated | Dose-reduced Versus Standard Conditioning in MDS/sAML Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia | Phase 3 | 2004-05-01 |
| Completed | Stem Cell Translpantation in Multiple Myeloma Multiple Myeloma | Phase 2 | 2001-09-01 |
| Terminated | Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G Aplastic Anaemia | Phase 3 | 2001-03-01 |
| Completed | Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 3 | 1995-01-01 |